Cellectis
CLLS
29 hedge funds and large institutions have $23M invested in Cellectis in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
100% more call options, than puts
Call options by funds: $6K | Put options by funds: $3K
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
10% more capital invested
Capital invested by funds: $20.9M → $23M (+$2.1M)
7% more funds holding
Funds holding: 27 → 29 (+2)
4.15% more ownership
Funds ownership: 13.55% → 17.7% (+4.2%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$997K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$427K |
| 3 |
Morgan Stanley
New York
|
+$200K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$37.2K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$23.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
-$881K |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$753K |
| 3 |
KBC Group
Brussels,
Belgium
|
-$347K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.8K |
| 5 |
LPL Financial
San Diego,
California
|
-$13.2K |
CLLS Hedge Fund Activity: Q4 2024 in Review
29 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2024, worth a combined $23M — up 10% from $20.9M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CLLS positions and 4 closed out — a net gain of 2 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $997K. The largest seller was Principal Financial Group, exiting entirely with an estimated $881K sold.
- 29 institutional investors held Cellectis (CLLS) as of Q4 2024, up from 27 in Q3 2024.
- Funds reported $23M of Cellectis stock for Q4 2024, up 10% quarter-over-quarter.
- 6 funds opened new Cellectis positions in Q4 2024 and 4 closed out, a net change of +2 holders.
- The largest Cellectis buyer in Q4 2024 was Millennium Management, an estimated $997K added.
- The largest Cellectis seller in Q4 2024 was Principal Financial Group, an estimated $881K sold.
Based on aggregated 13F filings for Q4 2024.